Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 12/20 | 0.60 |
| ▸ | CALCR | P30988 | 3/20 | 0.60 |
| ▸ | GCGR | P47871 | 9/20 | 0.57 |
| ▸ | GIPR | P48546 | 6/20 | 0.57 |
| ▸ | APLNR | P35414 | 1/20 | 0.56 |
| ▸ | NPY2R | P49146 | 1/20 | 0.56 |
| ▸ | NPY4R | P50391 | 1/20 | 0.56 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31656493 | 0.94 | CALCR (0.58) | GLP1RCALCRAPLNRNPY2RNPY4R | |
| SCHEMBL30567713 | 0.92 | NPY2R (0.57) | GLP1RCALCRAPLNRNPY2RNPY4R | |
| SCHEMBL30576977 | 0.90 | CALCR (0.57) | GLP1RCALCRGCGRGIPRNPY2R | |
| SCHEMBL31000900 | 0.89 | CALCR (0.57) | GLP1RCALCRGCGRGIPRAPLNR | |
| SCHEMBL29370426 | 0.89 | CALCR (0.67) | GLP1RCALCRNPY2RNPY4RNPY5R | |
| SCHEMBL30938250 | 0.89 | CALCR (0.67) | GLP1RCALCRNPY2RNPY4RNPY5R | |
| SCHEMBL30567785 | 0.89 | GLP1R (0.57) | GLP1RCALCRAPLNRNPY2RNPY4R | |
| SCHEMBL30938249 | 0.89 | CALCR (0.68) | CALCRNPY2RNPY4RNPY5R | |
| SCHEMBL29414492 | 0.89 | CALCR (0.68) | CALCRNPY2RNPY4RNPY5R | |
| SCHEMBL31754008 | 0.89 | CALCR (0.65) | GLP1RCALCRGCGRGIPRNPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4630447-A2 | ANTIBODIES OR FRAGMENTS THEREOF FOR SARS-COV-2 AND VARIANTS THEREOF | Abwiz Bio, Inc. (US) | 2025-10-15 | — | — | EP | disclosed |
| WO-2024124241-A2 | ANTIBODIES OR FRAGMENTS THEREOF FOR SARS-COV-2 AND VARIANTS THEREOF | ABWIZ BIO, INC. (US) | 2024-06-13 | — | — | WO | disclosed |